European Biotech Acquisition Corp Cl A (EBAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EBAC | ||||
| Company | European Biotech Acquisition Corp Cl A | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 11.09 | ||||
| High | 11.69 | ||||
| Low | 10.55 | ||||
| Latest | 11.19 | ||||
| Change | -0.52 | ||||
| % Change | -4.44% | ||||
| Volume | 83,800 | ||||
| 20-Day Average Volume | 269,585 | ||||
| Previous Close | 11.71 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 10.30 | ||||
| 20-Day Raw Stochastic | 39.60% | ||||
| 20-Day Relative Strength | 61.43 | ||||
| Weighted Alpha | +19.25 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 100% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.60% since 02/23/23 | ||||
| Low | 9.50 on 02/24/23 | ||||
| High | 14.10 on 03/01/23 | ||||
| 1-Month | |||||
| %Chg | +10.14% since 02/02/23 | ||||
| Low | 9.28 on 02/23/23 | ||||
| High | 14.10 on 03/01/23 | ||||
| 3-Month | |||||
| %Chg | +11.79% since 12/02/22 | ||||
| Low | 9.28 on 02/23/23 | ||||
| High | 14.10 on 03/01/23 | ||||
| 6-Month | |||||
| %Chg | +12.12% since 09/02/22 | ||||
| Low | 9.28 on 02/23/23 | ||||
| High | 14.10 on 03/01/23 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 342,895 | ||||
| Last Quarter Sales | 0 | ||||
| Last Quarter Net Income | -968,669 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||